КЛИНИЧЕСКИЙ СЛУЧАЙ РАЗВИТИЯ ГИПЕРКАЛЬЦИЕМИИ НА ФОНЕ ЛЕЧЕНИЯ АУТОИММУННОГО ГИПОПАРАТИРЕОЗА
Аннотация
В статье приводится анализ клинического случая дифференциальной диагностики гиперкальциемии у пациентки в возрасте 67 лет с аутоиммунным гипопаратиреозом, постменопаузальным остеопорозом. Терапия аутоиммунного гипопаратиреоза требует постоянного приема препаратов кальция и витамина D с систематическим мониторированием показателей фосфорно-кальциевого обмена. Развитие гиперкальциемии в данном клиническом случае связано с выявлением множественной миеломы.
Литература
Bilezikian JP, Khan A, Potts JT Jr, Brandi ML, Clarke BL, Shoback D, Jüppner H, Amour PD, Fox J, Rejnmark L, Mosekilde L, Rubin MR, Dempster D, Gafni R, Collins MT, Sliney J, Sanders J. Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. J. Bone Miner. Res. 2011;26:2317-2337. https://doi.org/10.1002/jbmr.483.
Shoback D. Clinical practice. Hypoparathyroidism. N. Engl. J. Med. 2008;359:391-403. https://doi.org/10.1056/NEJMcp0803050.
Bollerslev J, Rejnmark L, Marcocci C, Shoback DM, Sitges-Serra A, van Biesen W, Dekkers OM. European Society of endocrinology clinical guideline: Treatment of chronic hypoparathyroidism in adults. Eur J Endocrinol. 2015;173(2):1-20. https://doi.org/10.1530/EJE-15-0628.
Mokrysheva NG, Eremkina AK, Kovaleva EV. Gipoparatireoz: jetiologija, klinicheskaja kartina, sovremennye metody diagnostiki i lechenija [Hypoparathyroidism: etiology, clinical manifestation, current diagnostics and treatment]. Almanah klinicheskoj mediciny [Almanach of Clinical Medicine]. 2016;44(4):477-492. https://doi.org/10.18786/2072-0505-2016-44-4-477-492. (Russian).
Grebennikova TA, Belaja ZhE, Melnichenko GA. Gipoparatireoz: sovremennoe predstavlenie o zabolevanii i novye metody lechenija [Hypoparathyroidism: disease update and new methods of treatment]. Jendokrinnaja hirurgija [Endocrine Surgery]. 2017;11(2):70-80. https://doi.org/10.14341/serg2017270-80. (Russian).
Clarke BL. Epidemiology and complication of hepoparathyroidism. Endocrinol Metab. Clin. North. Am. 2018;14(4):771-782. https://doi.org/10.1016/j.ecl.2018.07.004.
Mannstadt M, Bilezikian JP, Thakker RV, Hannan FM, Clarke BL, Rejnmark L, Mitchell DM, Vokes TJ, Winer KK, Shoback DM. Hypoparathyroidism. Nat. Rev. Primeres. 2017;31(3):17055. https://doi.org/10.1038/nrdp.2017.55.
Astor MC, Lovas K, Debowska A, Eriksen EF, Evang JA, Fossum C, Fougner KJ, Holte SE, Lima K, Moe RB, Myhre AG, Kemp EH, Nedrebo BG, Svartberg J, Husebye ES. Epidemiology and health-related quality of life in hypoparathyroidism in Norway. J. Clin. Endocrinol. Metab. 2016;101(8):3045-3053. https://doi.org/10.1210/jc.2016-1477.
Powers J, Joy K, Ruscio A, Lagast H. Prevalence and incidence of hypoparathyroidism in the United States using a large claims database. J. Bone Miner. Res. 2013;28(12):2570-2576. https://doi.org/10.1002/jbmr.2004.
Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L. The еpidemiology of nonsurgical hypoparathyroidism in Denmark: a nationwide case finding study. J. Bone Miner. Res. 2015;30(9):1738-1744. https://doi.org/10.1002/jbmr.2501.
Osnovnaja jendokrinnaja patologija. Otnositelnye pokazateli. In: Respublikanskij centr medicinskoj reabilitacii i balneolechenija. Sravnitelnaja harakteristika dejatelnosti jendokrinologicheskoj sluzhby Respubliki Belarus za 2018: statisticheskij spravochnik [Comparative characteristics of the activities of the endocrinological service of the Republic of Belarus for 2018: statistical reference book]. Minsk; 2018. Ch. 4; р. 136. (Russian).
Goldmuntz E. Di George syndrome: new insights. Clin. Perinatol. 2005;32(4):963-978. https://doi.org/10.1016/j.clp.2005.09.006.
Thakker RV. Genetic developments in hypoparathyroidism. Lancet. 2001;57(9261):974-976. https://doi.org/10.1016/SO140-6736(00)04254-9.
Sanjad SA, Sakati NA, Abu-Osba YK, Kaddoura R, Milner RD. A new syndrome of congenital hypoparathyroidism, severe growth failure, and dysmorphic features. Arch. Dis. Child. 1991;66(2):193-196. https://doi.org/10.1136/adc.66.2.193.
Maceluch JA, Niedziela M. The clinical diagnosis and molecular genetics of kearns-sayre syndrome: a complex mitochondrial encephalomyopathy. Pediatr Endocrinol Rev. 2006-2007;4(2):117-137.
Powers J, Joy K, Ruscio A, Lagast H. Prevalence and incidence of hypoparathyroidism in the United States using a large claims database. J. Bone Miner. Res. 2013;28(12):2570-2576. https://doi.org/10.1002/jbmr.2004.
Eisenbarth GS, Gottlieb PA. Autoimmune polyendocrine syndromes. N. Engl. J. Med. 2004;350(20):2068-2079. https://doi.org/10.1056/NEJMra030158.
Larina АА, Shapovaljanc OS, Mazurina NV, Troshina EA. Diagnostika i lechenie autoimmunnogo poliglanduljarnogo sindroma u vzroslyh [Diagnostics and treatment of autoimmune polyglandular syndrome of adults]. Klinicheskaja medicina [Clinical Medicine]. 2012;8:64-66. (Russian).
Watanabe S, Fukumoto S, Chang H, Takeuchi Y, Hasegawa Y, Okazaki R, Chikatsu N, Fujita T. Association between activating mutations of calcium-sensing receptor and Bartter’s syndrome. Lancet. 2002;360(9334):692-694. https://doi.org/10.1016/S0140-6736(02)09842-2.
Vargas-Poussou R, Huang C, Hulin P, Houillier P, Jeunemaître X, Paillard M, Planelles G, Déchaux M, Miller RT, Antignac C. Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a Bartter-like syndrome. J. Am. Soc. Nephrol. 2002;13(9):2259-2266. https://doi.org/10.1097/01.ASN.0000025781.16723.68.
Mantovani G. Clinical review: Pseudohypoparathyroidism: diagnosis and treatment. J. Clin. Endocrinol. Metab. 2011;96(10):3020-3030. https://doi.org/10.1210/jc.2011-1048.
Mantovani G, Elli FM, Spada A. GNAS epigenetic defects and pseudohypoparathyroidism: time for a new classification? Horm. Metab. Res. 2012;44(10):716-723. https://doi.org/10.1055/s-0032-1314842.
Dedov II, Melnichenko GA, editors. Jendokrinologija: nacionalnoe rukovodstvо [Endocrinology: national leadership]. Moskva: GEOTAR-Media; 2016. 752 p. (Russian).
Shane E, Irani D. Hypercalcemia: pathogenesis, clinical manifestations, differential diagnosis, and management. In: Favus MJ, editor. Primer on the metabolic bone diseases and disorders of mineral metabolism. 6st ed. Washington DC: Am. Soc. for Bone and Miner. Res., 2006. Ch. 26; р. 176-180.
Rosner MH, Dalkin AC. Onco-nephrology: the pathophysiology and treatment of malignancy-associated hypercalcemia. Clin. J. Am. Soc. Nephrol. 2012;7:1722-1729. https://doi.org/10.2215/CJN.02470312.
Christensen SE, Nissen PH, Vestergaard P, Heickendorff L, Brixen K, Mosekilde L. Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow-up study on methods. Clin. Endocrinol. 2008;69:713-720. https://doi.org/10.1111/j.1365-2265.2008.03259.
Dedov II, Melnichenko GA, Shestakova MI, editors. Jendokrinologija. Farmakoterapija bez oshibok [Endocrinology. Pharmacotherapy without errors]. Moskva: E-noto; 2018. p. 194. (Russian).
Melnichenko GA, Udovichenko OV, Shvedova AE. Jendokrinologija: tipichnye oshibki prakticheskogo vracha [Endocrinology: typical mistakes of the practitioner]. Moskva: Prakticheskaja medicina; 2014. p. 78. (Russian).
Savage M, Mah P, Wellman A, Newell-Price J. Endocrine emergencies. Postgrad. Med. J. 2004;80:506-515.
Mihalev MA, Kuznecova EJu, Syrceva EB, SokolovaPopova TA. Klinicheskij sluchaj redkogo sochetanija mnozhestvennoj mielomy i mieloproliferativnogo zabolevnija [Clinical case of a rare combination of multiple myeloma and myeloproliferative disease]. Sovremennye problemy nauki i obrazovanija [Modern problems of science and education]. 2016;5:79-87. (Russian).
Low SF, Mohd Tap NH, Kew TY, Ngiu CS, Sridharan R. Non secretory multiple myeloma with extensive extramedullary plasmacytoma: a diagnostic dilemma. Iran. J. Radiol. 2015;12(3):11760. https://doi.org/10.5812/iranjradiol.11760v2.
Mostovoj VP, Iljasov RK, Muravskaja JuV. Problemy diagnostiki i lechenija nesekretirujushhej formy mnozhestvennoj mielomy [Problem diagnosis and treatment of non-secretory multiple myeloma form]. Krimskij terapevtichnij zhurnal [Crim therapeutic journal]. 2013;2:203-2016. (Russian).
Kemajkin VM. “Nesekretirujushhaja” mnozhestvennaja myeloma. Ch. 1 [“Non-secretive” multiple myeloma. Ch. 1]. Astana medicinalyқ zhurnaly [Astana Medical Journal]. 2011;68(6):22-25. (Russian).
Ryzhko VV, Kolodzinskij AA, Varlamova EJu, Sataeva MS, Kaplanskaja IB, Nakastoev IM, Paraskevova OV. “Nesekretirujushhaja” mnozhestvennaja myeloma [“Nonsecretive” multiple myeloma]. Klinicheskaja onkogematolgija [Clinical Oncohematology]. 2010;3(3):270-277. (Russian).
